AstraZeneca wins speedy approvals for cancer drugs in Japan

LONDON (Reuters) - AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets.

Roche 'highly encouraged' by Tecentriq results in breast cancer

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.

Britain's health service has started planning for Brexit no deal

LONDON (Reuters) - Britain's public health service has started "significant planning" to ensure medicines are still supplied to patients if the government fails to negotiate a Brexit deal with the European Union, its head said on Sunday.

Missouri appeals court tosses $55 million J&J talc-powder verdict

(Reuters) - A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J's baby powder, citing a U.S. Supreme court ruling on where such cases can be brought.

Iowa's top court rejects waiting period for abortions

(Reuters) - Iowa's Supreme Court on Friday rejected a 72-hour waiting period for abortions signed into law last year, ruling it unconstitutional.

AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge

(Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.

Rival Novartis, Gilead CAR-T therapies win European panel recommendation

ZURICH (Reuters) - Rival cancer cell therapies from Swiss drugmaker Novartis and U.S.-based Gilead Sciences won a key recommendation from a European Medicines Agency panel, likely clearing their way for approval within months.

FDA approves Dermira's wipe for excessive armpit sweating

(Reuters) - Dermira Inc said on Friday its topical cloth for excessive armpit sweating was approved by the U.S. Food and Drug Administration, providing patients with an easy-to-use option for an often embarrassing condition.

FDA approves Pulmonx's valve to treat lung disease

(Reuters) - The U.S. Food and Drug Administration on Friday approved Pulmonx Inc's valve to treat a severe form of obstructive lung disease, most often characterized by shortness of breath.

Amazon to buy PillPack in potentially disruptive drug retail push

(Reuters) - Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers.

Related Videos

Treadmill tests show polar bears to be efficient walkers

Polar bears consume no more energy than similarly sized animals while walking, according to new research which counters previous scientific thinking. The findings are important because Arctic ice shrinkage is forcing the creatures to travel further distances to hunt seals. Jim Drury reports.

Norway tests tiny electric plane, sees passenger flights by 2025

Norway has tested a two-seater electric plane, predicting a start to passenger flights by 2025 if new aviation technologies match a green shift that has made Norwegians the world's top buyers of electric cars, as Reuters' Alister Doyle discovered. Jim Drury reports.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here